<HTML>
<HEAD>
<TITLE>Psychiatric Solutions, Inc.</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt">AS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION ON AUGUST 24, 2004



<DIV align="right" style="font-size: 10pt">REGISTRATION NO. 333-<U>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</U></DIV>



<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">





<P align="center" style="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt">WASHINGTON, DC 20549
</DIV>


<P align="center" style="font-size: 10pt"><HR size="1" noshade width="35%" align="center">


<P align="center" style="font-size: 18pt"><B>Form&nbsp;S-8</B>


<P align="center" style="font-size: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</B>



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="35%" align="center">


<P align="center" style="font-size: 24pt"><B>PSYCHIATRIC SOLUTIONS, INC.</B>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>23-2491707</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>840 Crescent Centre Drive, Suite&nbsp;460</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top"><B>Franklin, Tennessee</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>37067</B></TD>
</TR>

<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan<BR>
Amended and Restated Psychiatric Solutions, Inc. Outside Directors&#146; Non-Qualified Stock<BR>
Option Plan</B><BR>
(Full title of the plan)



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="35%" align="center">



<P align="center" style="font-size: 10pt">Joey A. Jacobs<BR>
President and Chief Executive Officer<BR>
Psychiatric Solutions, Inc.<BR>
113 Seaboard Lane, Suite&nbsp;C-100<BR>
Franklin, Tennessee 37067<BR>
(Name and address of agent for service)



<P align="center" style="font-size: 10pt">(615)&nbsp;312-5700<BR>
(Telephone number, including area code, of agent for service)



<P align="center" style="font-size: 10pt">Copies of all communications to:<BR>
Christopher L. Howard, Esq.<BR>
Waller Lansden Dortch &#038; Davis, PLLC<BR>
511 Union Street, Suite&nbsp;2700<BR>
Nashville, Tennessee 37219-1760<BR>
(615)&nbsp;244-6380



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="35%" align="center">



<P align="center" style="font-size: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount Of</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Title Of Each Class Of Securities To Be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount To Be</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum Offering Price</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Maximum Aggregate</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registration</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Registered</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Registered</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Per Unit</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Offering Price</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Fee (5)</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">614,959 </TD>
    <TD nowrap>(1)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">22.24</TD>
    <TD nowrap>(4)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">13,676,688</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,733</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">1,008,097 </TD>
    <TD nowrap>(2)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">17.87</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">18,014,693</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">2,283</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px">Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">166,667 </TD>
    <TD nowrap>(3)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">$</TD>
    <TD align="right">22.24</TD>
    <TD nowrap>(4)</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,706,674</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">470</TD>
    <TD>&nbsp;</TD>
</TR>

<TR style="font-size: 1px">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="1" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="1" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="1" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="1" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:20px; text-indent:-10px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,789,723</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">35,398,055</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">4,486</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="4" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="4" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="4" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right"><HR size="4" noshade>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Represents shares of common stock, par value $.01 per share (&#147;Common
Stock&#148;), of Psychiatric Solutions, Inc. (&#147;Psychiatric Solutions&#148;) reserved
for issuance pursuant to future grants of stock options under the Amended
and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(the &#147;Equity Incentive Plan&#148;).</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Represents shares reserved for issuance under the Equity Incentive Plan
at a weighted-average exercise price of $17.87 per share.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(3)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Represents shares reserved for issuance pursuant to future grants of
stock options under the Amended and Restated Outside Directors&#146;
Non-Qualified Stock Option Plan (the &#147;Outside Directors&#146; Plan&#148;).</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(4)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Estimated pursuant to Rule 457(c) solely for purposes of calculating the
amount of the registration fee, based upon the average of the high and low
prices of Common Stock of Psychiatric Solutions, as reported on the Nasdaq
National Market on August&nbsp;19, 2004.</TD>
</TR>

</TABLE>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right">(5)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Equity Incentive Plan authorizes the issuance of a maximum of
2,933,333 shares of Common Stock, of which 478,566 shares have been
registered pursuant to a previously filed registration statement on Form
S-8 (No.&nbsp;333-38419), 333,333 shares have been registered on a previously
filed registration statement on Form&nbsp;S-8 (No.&nbsp;333-94983) and 166,666
shares have been registered on a previously filed registration statement
on Form&nbsp;S-8 (No.&nbsp;33-72664). In connection with the amendment and
restatement of the Equity Incentive Plan on May&nbsp;6, 2003, the Psychiatric
Solutions, Inc. 1997 Incentive and Non-Qualified Stock Option Plan for Key
Personnel (the &#147;Psychiatric Plan&#148;) was merged into the Equity Incentive
Plan. The Psychiatric Plan authorized the issuance of a maximum of
331,712 shares of Common Stock, all of which shares have been registered
pursuant to a previously filed registration statement on Form&nbsp;S-8 (No.
333-100635). In addition, the Outside Directors&#146; Plan authorizes the
issuance of a maximum of 341,667 shares of Common Stock, of which 175,000
shares have been registered pursuant to a previously filed registration
statement on Form&nbsp;S-8 (No.&nbsp;33-72664). An additional 1,789,723 shares of
Common Stock are being registered herewith and, in accordance with General
Instruction E of Form S-8, the fee is being paid only with respect to
these shares. All share numbers, purchase prices per share and exercise
prices set forth in this registration statement have been adjusted to
reflect the exchange ratio in the merger between Psychiatric Solutions and
PMR Corporation on August&nbsp;5, 2002 and to reflect a 1-for-3 reverse stock
split effected on August&nbsp;5, 2002.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="center" style="font-size: 10pt"><B>Reoffer Prospectus</B>



<P align="center" style="font-size: 14pt"><B>1,789,723 Shares</B>



<P align="center" style="font-size: 24pt"><B>Psychiatric Solutions, Inc.</B>



<P align="center" style="font-size: 14pt"><B>Common
Stock</B><HR noshade size="1" width="20%" align="center">



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus has been prepared for use by certain affiliates and
employees (the &#147;Selling Stockholders&#148;) of Psychiatric Solutions, Inc.
(&#147;Psychiatric Solutions&#148;) who may offer and sell up to an aggregate of
1,789,723 shares of common stock, par value $.01 per share (&#147;Common Stock&#148;),
that the Selling Stockholders acquire pursuant to the Amended and Restated
Psychiatric Solutions, Inc. Equity Incentive Plan, as amended (the &#147;Incentive
Plan&#148;), and the Amended and Restated Psychiatric Solutions, Inc. Outside
Directors&#146; Non-Qualified Stock Option Plan (the &#147;Outside Directors&#146; Plan&#148;), or
upon the exercise, subsequent to the date of this reoffer prospectus, of stock
options granted pursuant to the Incentive Plan or the Outside Directors&#146; Plan.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus may only be used in conjunction with a supplement, if
required under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;),
that contains the names of the Selling Stockholders and the amount of shares of
Common Stock to be reoffered by them except with respect to sales by
non-affiliates of no more than the lesser of 1,000 shares or one percent of the
shares issuable under the Incentive Plan or the Outside Directors&#146; Plan.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any of the proceeds from the sale of the shares by the
Selling Stockholders. We will bear all expenses (other than underwriting
discounts and selling commissions, fees and expenses of counsel and other
advisors to the Selling Stockholders, transfer taxes and related charges) in
connection with the registration of the shares being offered by the Selling
Stockholders.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Common Stock is listed on the Nasdaq National Market under the symbol
&#147;PSYS.&#148; We are incorporated under the laws of the State of Delaware. Our
principal executive offices are located at 840 Crescent Centre Drive, Suite
460, Franklin, Tennessee 37067 and our telephone number is (615)&nbsp;312-5700.
<P>
<HR noshade size="1" width="20%" align="center">

<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Investing in our Common Stock involves certain risks. Please carefully
consider the &#147;Risk Factors&#148; in our Annual Report on </B><B>Form 10-K</B><B> filed on March
25, 2004, and incorporated by reference into this prospectus.</B>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Neither the Securities and Exchange Commission (the &#147;SEC&#148;) nor any state
securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to
the contrary is a criminal offense.</B>


<P align="center" style="font-size: 10pt">The date of this prospectus
is August&nbsp;24, 2004.



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>TABLE OF CONTENTS</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="92%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Heading</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Page</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#101">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#102">Selling Stockholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#103">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#104">Available Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#105">Incorporation of Certain Information By Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#106">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><A href="#107">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g90685exv5w1.txt">Ex-5.1 Opinion of Waller Lansden Dortch & Davis, PLLC</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g90685exv23w1.txt">Ex-23.1 Consent of Ernst & Young LLP</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g90685exv23w2.txt">Ex-23.2 Consent of Crowe Chizek and Company LLC</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="g90685exv23w3.txt">Ex-23.3 Consent of Selznick & Company, LLP</A></FONT></TD></TR>
</TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<A name="101"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>USE OF PROCEEDS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any proceeds from the sale of shares of Common Stock
by the Selling Stockholders.

<DIV align="left">
<A name="102"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>SELLING STOCKHOLDERS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares of Common Stock issued pursuant to the Incentive Plan or the
Outside Directors&#146; Plan, or upon the exercise, subsequent to the date of this
reoffer prospectus, of stock options granted pursuant to the Incentive Plan or
the Outside Directors&#146; Plan have been registered under the Securities Act, by a
registration statement on Form S-8. This prospectus is to be used in
connection with any resales of Common Stock acquired pursuant to the Incentive
Plan or the Outside Directors&#146; Plan after the date of the registration
statement on Form S-8 by persons who may be considered our &#147;affiliates&#148; within
the meaning of the Securities Act and other persons who, although not
affiliates, may hold restricted securities previously issued through an
employee benefit plan.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the date of this prospectus, we do not know the names of persons who
intend to resell shares of Common Stock acquired pursuant to the Incentive Plan
or the Outside Directors&#146; Plan. The Selling Stockholders will be either
employees, directors, consultants or advisors of Psychiatric Solutions or its
subsidiaries who have been or may be granted options to purchase Common Stock
or restricted shares of Common Stock under the Incentive Plan or the Outside
Directors&#146; Plan. We will supplement this prospectus with the names of the
Selling Stockholders and the amount of shares of Common Stock to be reoffered
by them as that information becomes known and is required by the Securities
Act.

<DIV align="left">
<A name="103"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>PLAN OF DISTRIBUTION</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be offered by the Selling Stockholders from time to time in
transactions through the Nasdaq National Market, in negotiated transactions,
through the writing of options on the shares or a combination of these methods
of sale, at prices related to prevailing market prices or at negotiated prices.
The Selling Stockholders may effect these transactions by selling the shares to
or through broker-dealers and these broker-dealers may receive compensation in
the form of discounts, concessions or commissions from the Selling Stockholders
and/or the purchaser of the shares for which such broker-dealers may act as
agent or to whom they sell as principal, or both. This compensation as to a
particular broker-dealer may be in excess of customary commissions.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no assurance that any of the Selling Stockholders will sell any
or all of the shares of Common Stock offered under this prospectus.

<DIV align="left">
<A name="104"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>AVAILABLE INFORMATION</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and, in accordance
therewith, we file reports, proxy statements and other information with the SEC
under the Exchange Act. You may read and copy this information on our website
at www.psysolutions.com and at the following locations of the SEC:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Public Reference Room
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York Regional Office
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago Regional Office</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">450 Fifth Street, N.W.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Woolworth Center
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Citicorp Center, Suite&nbsp;1400</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Room&nbsp;1024
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">233 Broadway
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">500 West Madison Street</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Washington, D.C. 20549
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10279
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chicago, IL 60661-2511</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may also obtain copies of this information by mail from the Public
Reference Section of the SEC, 450 Fifth Street, N.W., Room&nbsp;1024, Washington,
D.C. 20549, at prescribed rates. You may obtain information on the operation of
the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also
maintains an Internet world wide web site that contains reports, proxy
statements and other information about issuers, like us, that file
electronically with the SEC. The address of that site is http://www.sec.gov.
You may also inspect reports, proxy statements and other information about us
at the offices of the Nasdaq Stock Market, 9600 Blackwell Road, Rockville,
Maryland 20850.

<DIV align="left">
<A name="105"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The SEC allows us to &#147;incorporate by reference&#148; information into this
prospectus from documents that we have previously filed with the SEC. This
means that we can disclose important information to you by referring you to
another document filed separately with the SEC. These documents contain
important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except
for any information that is superseded by other information that is set forth
directly in this document.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus incorporates by reference the following documents with
respect to us (file number: 0-20488):


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">1.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our annual report on Form 10-K for the year ended December
31, 2003;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">2.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our quarterly reports on Form 10-Q for the quarters ended
March&nbsp;31, 2004 and June&nbsp;30, 2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">3.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Our current reports on Form 8-K dated March&nbsp;3, 2004, as
amended on May&nbsp;12, 2004, and June&nbsp;2, 2004, as amended on August&nbsp;10,
2004;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="4%" nowrap align="right">4.</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of our common stock contained in registration
statement on Form S-4 filed with the SEC on June&nbsp;12, 2002, as
amended July&nbsp;11, 2002.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We incorporate by reference additional documents that we will file with
the SEC pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act
between the date of this prospectus and the termination dates of the Incentive
Plan and the Outside Directors&#146; Plan. These documents include periodic
reports, such as annual reports on Form 10-K, quarterly reports on Form 10-Q
and current reports on Form 8-K, as well as proxy statements.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the extent that any statement in this prospectus is inconsistent with
any statement that is incorporated by reference, the statement in this
prospectus shall control. The incorporated statement shall not be deemed,
except as modified or superseded, to constitute a part of this prospectus or
the registration statement.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You may obtain copies of the documents incorporated by reference in this
prospectus with respect to us without charge, excluding any exhibits to those
documents unless the exhibit is specifically incorporated by reference as an
exhibit in this prospectus, by requesting them in writing or by telephone from
Brent Turner, Investor Relations, Psychiatric Solutions, Inc., 840 Crescent
Centre Drive, Suite&nbsp;460, Franklin, Tennessee 37067; (615)&nbsp;312-5700. You may
also obtain copies of these documents from the SEC through the SEC&#146;s Internet
world wide web site or at the SEC&#146;s address or phone number described in the
section captioned &#147;AVAILABLE INFORMATION&#148; above.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have filed with the SEC a registration statement on Form S-8 under the
Securities Act with respect to Common Stock offered under this prospectus.
This prospectus does not contain all of


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">the information in the registration
statement on Form S-8, parts of which we have omitted, as allowed under the
rules and regulations of the SEC. You should refer to the registration
statement on Form S-8 for further information with respect to us and our Common
Stock. Statements contained in this prospectus as to the contents of any
contract or other document are not necessarily complete and, in each instance,
we refer you to the copy of each contract or document filed as an exhibit to
the registration statement on Form S-8. Copies of the registration statement
on Form S-8, including exhibits, may be inspected without charge at the SEC&#146;s
principal office in Washington, D.C. and copied upon payment of the fees
prescribed by the SEC.


<DIV align="left">
<A name="106"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>LEGAL MATTERS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of shares of our Common Stock offered under this prospectus
will be passed upon on our behalf by Waller Lansden Dortch &#038; Davis, PLLC,
Nashville, Tennessee.

<DIV align="left">
<A name="107"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>EXPERTS</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
consolidated financial statements of Psychiatric Solutions appearing
in Psychiatric Solutions&#146; Annual Report (Form 10-K) for the year
ended December&nbsp;31, 2003, have been audited by Ernst &#038; Young
LLP, independent registered public accounting firm, as set forth in
their report thereon included therein and incorporated herein by
reference. Such consolidated financial statements are incorporated
herein by reference in reliance upon such report given on the
authority of such firm as experts in accounting and auditing.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of Brentwood Health Management, LLC
and subsidiaries as of December&nbsp;31, 2003 and for the year then ended
incorporated in this registration statement by reference from the Amended
Current Report on Form 8-K/A filed by Psychiatric Solutions, Inc. on May&nbsp;12,
2004, have been audited by Crowe Chizek and Company LLC, independent registered
public accounting firm, as stated in their report, which is incorporated herein
by reference, and has been so incorporated in reliance upon the report of such
firm given upon their authority as experts in auditing and accounting.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The combined financial statements of Northern Healthcare Associates and
subsidiaries for the years ended December&nbsp;31, 2003 and 2002 incorporated in
this registration statement by reference from the Amended Current Report on
Form 8-K/A filed by Psychiatric Solutions, Inc. on August&nbsp;10, 2004, have been
audited by Selznick &#038; Company, LLP, independent registered public accounting
firm, as stated in their report, which is incorporated herein by reference, and
has been so incorporated in reliance upon the report of such firm given their
authority as experts in auditing and accounting.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY
INFORMATION OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS
PROSPECTUS IN CONNECTION WITH THE OFFERING HEREIN CONTAINED AND, IF GIVEN OR
MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING
BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS
PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER
TO BUY, THE SECURITIES OFFERED HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM
IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION. NEITHER THE DELIVERY OF THIS
PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES, CREATE
AN IMPLICATION THAT THERE HAS
BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE HEREOF OR</B>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt"><B>THAT
ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS
DATE.</B>



<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<P align="center" style="font-size: 10pt"><B>EXPLANATORY NOTE</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This registration statement on Form S-8 relates to the registration of an
additional 1,789,723 shares of Common Stock (the &#147;Additional Shares&#148;). The
Additional Shares are securities of the same class as those shares registered
in the Registrant&#146;s registration statements on Form S-8, previously filed with
the SEC (Registration Nos. 333-38419, 333-94983, 333-100635 and 33-72664) filed
on October&nbsp;21, 1997, January&nbsp;19, 2000, October&nbsp;18, 2002 and December&nbsp;8, 1993,
respectively, which, pursuant to General Instruction E of Form S-8, are
incorporated by reference herein.


<P align="center" style="font-size: 10pt"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>


<P align="left" style="font-size: 10pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under Section&nbsp;145 of the Delaware Corporation Law, we are empowered to
indemnify our directors and officers in circumstances therein provided.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Amended and Restated Certificate of Incorporation, as amended,
provides that no director shall be personally liable to us or our stockholders
for monetary damages for any breach of fiduciary duty by such director as a
director, except (i)&nbsp;for breach of the director&#146;s duty of loyalty to us or our
stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii)&nbsp;pursuant to Section
174 of the Delaware General Corporation Law, or (iv)&nbsp;for any transaction from
which the director derived an improper personal benefit.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under our Amended and Restated Bylaws, we must indemnify any person who
was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of
Psychiatric Solutions) by reason of the fact that he or she is or was a
director, officer, employee or agent of Psychiatric Solutions, or is or was
serving at our request as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against
expenses (including attorneys&#146; fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by him or her in connection with
such action, suit or proceeding if he or she acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his or her conduct was unlawful. The termination of
any action, suit or proceeding by judgment, order, settlement, conviction, or
upon a plea of nolo contendere or its equivalent, shall not, of itself, create
a presumption that the person did not act in good faith and in a manner which
he or she reasonably believed to be in or not opposed to our best interests,
and, with respect to any criminal action or proceeding, had reasonable cause to
believe that his or her conduct was unlawful.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We must also indemnify any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed action or suit by or
in the right of Psychiatric Solutions to procure a judgment in its favor by
reason of the fact that he or she is or was a director, officer, employee or
agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise against expenses (including attorneys&#146; fees)
actually and reasonably incurred by him or her in connection with the defense
or settlement of such action or suit if he or she acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to our best
interests, except that no indemnification shall be made in respect of any
claim, issue or matter as to which such person shall have been adjudged to be
liable for negligence or misconduct in the performance of his duty to us


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">unless and only to the extent that the Court of Chancery or the court in
which such action or suit was brought shall determine upon application that,
despite the adjudication of liability but in view of all the circumstances of
the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We may purchase and maintain insurance, at our expense, to protect us and
any of our directors, officers, employees or agents or the directors, officers,
employees or agents of another corporation, partnership, joint venture, trust
or other enterprise, against any such expense, liability or loss, to the
fullest extent permitted by the Delaware General Corporation Law.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to separate indemnification agreements we have entered into with
each of our directors, we must indemnify and advance expenses to each director
to the fullest extent permitted by law and as set forth in each agreement and,
to the extent applicable, maintain insurance for the coverage of each director
under our policies of directors&#146; and officers&#146; liability insurance.

<P align="left" style="font-size: 10pt"><B>Item&nbsp;8. Exhibits.</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description of Exhibits</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of PMR Corporation,
filed with the Delaware Secretary of State on March&nbsp;9, 1998 (incorporated
by reference to Exhibit&nbsp;3.1 to the Company&#146;s Annual Report on Form&nbsp;10-K
for the fiscal year ended April&nbsp;30, 1998).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of
Incorporation of PMR Corporation, filed with the Delaware Secretary of
State on August&nbsp;5, 2002 (incorporated by reference to Exhibit&nbsp;3.2 to the
Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended July&nbsp;31,
2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of
Incorporation of Psychiatric Solutions, Inc., filed with the Delaware
Secretary of State on March&nbsp;21, 2003 (incorporated by reference to
Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January
22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to
the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended April
30, 1997).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reference is made to Exhibits 3.1 through 3.4.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Common Stock Specimen Certificate (incorporated by reference to Exhibit
4.2 to the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended
December&nbsp;31, 2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Contingent Value Rights Agreement, dated August&nbsp;2, 2002 (incorporated by
reference to Exhibit&nbsp;4.1 to the Company&#146;s Current Report on Form&nbsp;8-K,
filed on August&nbsp;5, 2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stock Purchase Agreement, dated as of January&nbsp;6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix&nbsp;B of the Company&#146;s Definitive Proxy Statement,
filed January&nbsp;22, 2003).</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description of Exhibits</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement, dated as of January&nbsp;6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix&nbsp;C of the Company&#146;s Definitive Proxy Statement,
filed January&nbsp;22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Designations, Preferences and Rights of Series&nbsp;A
Convertible Preferred Stock, filed with the Delaware Secretary of State on
March&nbsp;24, 2003 (incorporated by reference to Appendix&nbsp;D of the Company&#146;s
Definitive Proxy Statement, filed January&nbsp;22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Waller Lansden Dortch &#038; Davis, PLLC</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Crowe Chizek and Company LLC</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.3*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Selznick &#038; Company, LLP</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.4*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Waller Lansden Dortch &#038; Davis, PLLC (included in Exhibit&nbsp;5.1)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on page II-6)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy
Statement, filed on April&nbsp;9, 2004)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Outside Directors&#146; Stock
Option Plan (incorporated by reference to Appendix&nbsp;C to the Company&#146;s
Definitive Proxy Statement, filed on April&nbsp;14, 2003)</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>




<P>
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top">
    <TD width="100%">*Filed herewith</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">





<P align="left" style="font-size: 10pt"><B>Item&nbsp;9. Undertakings.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned registrant hereby undertakes:



<P align="left" style="margin-left:3%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:



<P align="left" style="margin-left:5%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section&nbsp;10(a)(3) of
the Securities Act of 1933;



<P align="left" style="margin-left:5%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information
set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price
represent no more than a 20&nbsp;percent change in the maximum aggregate
offering price set forth in the &#147;Calculation of Registration Fee&#148;
table in the effective registration statement;



<P align="left" style="margin-left:5%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration
statement or any material change of such information in the
registration statement.



<P align="left" style="margin-left:3%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Provided, however</I>, that paragraphs 1(i) and 1(ii) do not apply if
the information required to be included in a post-effective amendment by
those paragraphs is contained in periodic reports filed with or furnished
to the Commission by the registrant pursuant to Section&nbsp;13 or 15(d) of
the Securities Exchange Act of 1934 that are incorporated by reference in
the registration statement.



<P align="left" style="margin-left:3%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purposes of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.



<P align="left" style="margin-left:3%; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at
the termination of the offering.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant&#146;s annual report pursuant to Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan&#146;s annual report pursuant to Section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been informed that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is therefore unenforceable. In the event that a claim for
indemnification against such liabilities (other


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<P align="left" style="font-size: 10pt">than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such
issue.



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<A name="108"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Franklin, State of Tennessee, on August&nbsp;9, 2004.


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top">&nbsp;</TD>
    <TD colspan="3">PSYCHIATRIC SOLUTIONS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000">/s/ Joey A. Jacobs
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2">Joey A. Jacobs&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2"><I>Chairman, Chief Executive Officer
and President</I>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt"><B>POWER OF ATTORNEY</B>




<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below constitutes and appoints Joey A. Jacobs and Jack E. Polson, and each of
them, his true and lawful attorney-in-fact, as agent and with full power of
substitution and resubstitution for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments to this Registration
Statement, and to file the same, with all exhibits thereto and other documents
in connection therewith, with the Securities and Exchange Commission, granting
unto said attorney-in-fact and agents full power and authority to do and
perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully and to all intents and purposes as they might or
could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents or any substitute or substitutes of any of them,
may lawfully do or cause to be done by virtue hereof.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="41%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="16%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>SIGNATURE</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>TITLE</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>DATE</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Joey A. Jacobs
<HR size="1" noshade>
Joey A. Jacobs
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman, Chief
Executive Officer and
President (Principal
Executive Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Jack E. Polson
<HR size="1" noshade>
Jack E. Polson
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Accounting Officer
(Principal Financial and
Accounting Officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ William F. Carpenter III
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">William F. Carpenter III</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark P. Clein
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Mark P. Clein</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Richard Gore
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Richard Gore</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="41%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="16%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>SIGNATURE</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>TITLE</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>DATE</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Christopher Grant, Jr.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Christopher Grant, Jr.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ann H. Lamont
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ann H. Lamont</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Edward K. Wissing
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">August&nbsp;9, 2004</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><HR size="1" noshade></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Edward K. Wissing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left">
<A name="109"></A>
</DIV>

<P align="center" style="font-size: 10pt"><B>INDEX TO EXHIBITS</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description of Exhibits</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of PMR Corporation,
filed with the Delaware Secretary of State on March&nbsp;9, 1998 (incorporated
by reference to Exhibit&nbsp;3.1 to the Company&#146;s Annual Report on Form&nbsp;10-K
for the fiscal year ended April&nbsp;30, 1998).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of
Incorporation of PMR Corporation, filed with the Delaware Secretary of
State on August&nbsp;5, 2002 (incorporated by reference to Exhibit&nbsp;3.2 to the
Company&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended July&nbsp;31,
2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Amendment to Amended and Restated Certificate of
Incorporation of Psychiatric Solutions, Inc., filed with the Delaware
Secretary of State on March&nbsp;21, 2003 (incorporated by reference to
Appendix&nbsp;A of the Company&#146;s Definitive Proxy Statement, filed on January
22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">3.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Bylaws (incorporated by reference to Exhibit&nbsp;3.2 to
the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended April
30, 1997).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reference is made to Exhibits 3.1 through 3.4.</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Common Stock Specimen Certificate (incorporated by reference to Exhibit
4.2 to the Company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended
December&nbsp;31, 2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.3
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Contingent Value Rights Agreement, dated August&nbsp;2, 2002 (incorporated by
reference to Exhibit&nbsp;4.1 to the Company&#146;s Current Report on Form&nbsp;8-K,
filed on August&nbsp;5, 2002).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.4
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stock Purchase Agreement, dated as of January&nbsp;6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix&nbsp;B of the Company&#146;s Definitive Proxy Statement,
filed January&nbsp;22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.5
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Registration Rights Agreement, dated as of January&nbsp;6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix&nbsp;C of the Company&#146;s Definitive Proxy Statement,
filed January&nbsp;22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.6
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Designations, Preferences and Rights of Series&nbsp;A
Convertible Preferred Stock, filed with the Delaware Secretary of State on
March&nbsp;24, 2003 (incorporated by reference to Appendix&nbsp;D of the Company&#146;s
Definitive Proxy Statement, filed January&nbsp;22, 2003).</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Waller Lansden Dortch &#038; Davis, PLLC</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Ernst &#038; Young LLP</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Crowe Chizek and Company LLC</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>&nbsp;</B></TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Description of Exhibits</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.3*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Selznick &#038; Company, LLP</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.4*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Waller Lansden Dortch &#038; Davis, PLLC (included in Exhibit&nbsp;5.1)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1*
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on page II-6)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(incorporated by reference to Appendix&nbsp;A to the Company&#146;s Definitive Proxy
Statement, filed on April&nbsp;9, 2004)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Psychiatric Solutions, Inc. Outside Directors&#146; Stock
Option Plan (incorporated by reference to Appendix&nbsp;C to the Company&#146;s
Definitive Proxy Statement, filed April&nbsp;14, 2003)</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>




<P>
<HR size="1" width="18%" align="left" noshade>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top">
    <TD width="100%">*Filed herewith</TD>
</TR>

</TABLE>




<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g90685sv8.htm", "description": "PSYCHIATRIC SOLUTIONS, INC.", "secsgml_size_bytes": 82558}]
{"company-data": {"conformed-name": "PSYCHIATRIC SOLUTIONS INC", "cik": "0000829608", "assigned-sic": "8093", "irs-number": "232491707", "state-of-incorporation": "DE", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-118529", "film-number": "04994900"}, "business-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067", "phone": "615-312-5700"}, "mail-address": {"street1": "113 SEABOARD LANE", "street2": "SUITE C-100", "city": "FRANKLIN", "state": "TN", "zip": "37067"}, "former-company": [{"former-conformed-name": "PMR CORP", "date-changed": "19920703"}, {"former-conformed-name": "ZARON CAPITAL INC", "date-changed": "19891116"}]}
Psychiatric Solutions, Inc.
Table of Contents
AS FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION ON AUGUST 24, 2004
REGISTRATION NO. 333-
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
PSYCHIATRIC SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware
23-2491707
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
840 Crescent Centre Drive, Suite 460
Franklin, Tennessee
37067
(Address of principal executive offices)
(Zip Code)
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
Amended and Restated Psychiatric Solutions, Inc. Outside Directors' Non-Qualified Stock
Option Plan
(Full title of the plan)
Joey A. Jacobs
President and Chief Executive Officer
Psychiatric Solutions, Inc.
113 Seaboard Lane, Suite C-100
Franklin, Tennessee 37067
(Name and address of agent for service)
(615) 312-5700
(Telephone number, including area code, of agent for service)
Copies of all communications to:
Christopher L. Howard, Esq.
Waller Lansden Dortch & Davis, PLLC
511 Union Street, Suite 2700
Nashville, Tennessee 37219-1760
(615) 244-6380
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Amount Of
Title Of Each Class Of Securities To Be
Amount To Be
Maximum Offering Price
Maximum Aggregate
Registration
Registered
Registered
Per Unit
Offering Price
Fee (5)
Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share
614,959
(1)
$
22.24
(4)
$
13,676,688
$
1,733
Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share
1,008,097
(2)
$
17.87
$
18,014,693
$
2,283
Common Stock of Psychiatric Solutions,
Inc., par value $0.01 per share
166,667
(3)
$
22.24
(4)
$
3,706,674
$
470
Total
1,789,723
—
$
35,398,055
$
4,486
(1)
Represents shares of common stock, par value $.01 per share ("Common
Stock"), of Psychiatric Solutions, Inc. ("Psychiatric Solutions") reserved
for issuance pursuant to future grants of stock options under the Amended
and Restated Psychiatric Solutions, Inc. Equity Incentive Plan, as amended
(the "Equity Incentive Plan").
(2)
Represents shares reserved for issuance under the Equity Incentive Plan
at a weighted-average exercise price of $17.87 per share.
(3)
Represents shares reserved for issuance pursuant to future grants of
stock options under the Amended and Restated Outside Directors'
Non-Qualified Stock Option Plan (the "Outside Directors' Plan").
(4)
Estimated pursuant to Rule 457(c) solely for purposes of calculating the
amount of the registration fee, based upon the average of the high and low
prices of Common Stock of Psychiatric Solutions, as reported on the Nasdaq
National Market on August 19, 2004.
(5)
The Equity Incentive Plan authorizes the issuance of a maximum of
2,933,333 shares of Common Stock, of which 478,566 shares have been
registered pursuant to a previously filed registration statement on Form
S-8 (No. 333-38419), 333,333 shares have been registered on a previously
filed registration statement on Form S-8 (No. 333-94983) and 166,666
shares have been registered on a previously filed registration statement
on Form S-8 (No. 33-72664). In connection with the amendment and
restatement of the Equity Incentive Plan on May 6, 2003, the Psychiatric
Solutions, Inc. 1997 Incentive and Non-Qualified Stock Option Plan for Key
Personnel (the "Psychiatric Plan") was merged into the Equity Incentive
Plan. The Psychiatric Plan authorized the issuance of a maximum of
331,712 shares of Common Stock, all of which shares have been registered
pursuant to a previously filed registration statement on Form S-8 (No.
333-100635). In addition, the Outside Directors' Plan authorizes the
issuance of a maximum of 341,667 shares of Common Stock, of which 175,000
shares have been registered pursuant to a previously filed registration
statement on Form S-8 (No. 33-72664). An additional 1,789,723 shares of
Common Stock are being registered herewith and, in accordance with General
Instruction E of Form S-8, the fee is being paid only with respect to
these shares. All share numbers, purchase prices per share and exercise
prices set forth in this registration statement have been adjusted to
reflect the exchange ratio in the merger between Psychiatric Solutions and
PMR Corporation on August 5, 2002 and to reflect a 1-for-3 reverse stock
split effected on August 5, 2002.
Table of Contents
Reoffer Prospectus
1,789,723 Shares
Psychiatric Solutions, Inc.
Common
Stock
This prospectus has been prepared for use by certain affiliates and
employees (the "Selling Stockholders") of Psychiatric Solutions, Inc.
("Psychiatric Solutions") who may offer and sell up to an aggregate of
1,789,723 shares of common stock, par value $.01 per share ("Common Stock"),
that the Selling Stockholders acquire pursuant to the Amended and Restated
Psychiatric Solutions, Inc. Equity Incentive Plan, as amended (the "Incentive
Plan"), and the Amended and Restated Psychiatric Solutions, Inc. Outside
Directors' Non-Qualified Stock Option Plan (the "Outside Directors' Plan"), or
upon the exercise, subsequent to the date of this reoffer prospectus, of stock
options granted pursuant to the Incentive Plan or the Outside Directors' Plan.
This prospectus may only be used in conjunction with a supplement, if
required under the Securities Act of 1933, as amended (the "Securities Act"),
that contains the names of the Selling Stockholders and the amount of shares of
Common Stock to be reoffered by them except with respect to sales by
non-affiliates of no more than the lesser of 1,000 shares or one percent of the
shares issuable under the Incentive Plan or the Outside Directors' Plan.
We will not receive any of the proceeds from the sale of the shares by the
Selling Stockholders. We will bear all expenses (other than underwriting
discounts and selling commissions, fees and expenses of counsel and other
advisors to the Selling Stockholders, transfer taxes and related charges) in
connection with the registration of the shares being offered by the Selling
Stockholders.
Our Common Stock is listed on the Nasdaq National Market under the symbol
"PSYS." We are incorporated under the laws of the State of Delaware. Our
principal executive offices are located at 840 Crescent Centre Drive, Suite
460, Franklin, Tennessee 37067 and our telephone number is (615) 312-5700.
Investing in our Common Stock involves certain risks. Please carefully
consider the "Risk Factors" in our Annual Report on
Form 10-K
filed on March
25, 2004, and incorporated by reference into this prospectus.
Neither the Securities and Exchange Commission (the "SEC") nor any state
securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to
the contrary is a criminal offense.
The date of this prospectus
is August 24, 2004.
TABLE OF CONTENTS
Heading
Page
Use of Proceeds
1
Selling Stockholders
1
Plan of Distribution
1
Available Information
1
Incorporation of Certain Information By Reference
2
Legal Matters
3
Experts
3
Ex-5.1 Opinion of Waller Lansden Dortch & Davis, PLLC
Ex-23.1 Consent of Ernst & Young LLP
Ex-23.2 Consent of Crowe Chizek and Company LLC
Ex-23.3 Consent of Selznick & Company, LLP
Table of Contents
USE OF PROCEEDS
We will not receive any proceeds from the sale of shares of Common Stock
by the Selling Stockholders.
SELLING STOCKHOLDERS
The shares of Common Stock issued pursuant to the Incentive Plan or the
Outside Directors' Plan, or upon the exercise, subsequent to the date of this
reoffer prospectus, of stock options granted pursuant to the Incentive Plan or
the Outside Directors' Plan have been registered under the Securities Act, by a
registration statement on Form S-8. This prospectus is to be used in
connection with any resales of Common Stock acquired pursuant to the Incentive
Plan or the Outside Directors' Plan after the date of the registration
statement on Form S-8 by persons who may be considered our "affiliates" within
the meaning of the Securities Act and other persons who, although not
affiliates, may hold restricted securities previously issued through an
employee benefit plan.
At the date of this prospectus, we do not know the names of persons who
intend to resell shares of Common Stock acquired pursuant to the Incentive Plan
or the Outside Directors' Plan. The Selling Stockholders will be either
employees, directors, consultants or advisors of Psychiatric Solutions or its
subsidiaries who have been or may be granted options to purchase Common Stock
or restricted shares of Common Stock under the Incentive Plan or the Outside
Directors' Plan. We will supplement this prospectus with the names of the
Selling Stockholders and the amount of shares of Common Stock to be reoffered
by them as that information becomes known and is required by the Securities
Act.
PLAN OF DISTRIBUTION
The shares may be offered by the Selling Stockholders from time to time in
transactions through the Nasdaq National Market, in negotiated transactions,
through the writing of options on the shares or a combination of these methods
of sale, at prices related to prevailing market prices or at negotiated prices.
The Selling Stockholders may effect these transactions by selling the shares to
or through broker-dealers and these broker-dealers may receive compensation in
the form of discounts, concessions or commissions from the Selling Stockholders
and/or the purchaser of the shares for which such broker-dealers may act as
agent or to whom they sell as principal, or both. This compensation as to a
particular broker-dealer may be in excess of customary commissions.
There is no assurance that any of the Selling Stockholders will sell any
or all of the shares of Common Stock offered under this prospectus.
AVAILABLE INFORMATION
We are subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and, in accordance
therewith, we file reports, proxy statements and other information with the SEC
under the Exchange Act. You may read and copy this information on our website
at www.psysolutions.com and at the following locations of the SEC:
Public Reference Room
New York Regional Office
Chicago Regional Office
450 Fifth Street, N.W.
Woolworth Center
Citicorp Center, Suite 1400
Room 1024
233 Broadway
500 West Madison Street
Washington, D.C. 20549
New York, NY 10279
Chicago, IL 60661-2511
1
Table of Contents
You may also obtain copies of this information by mail from the Public
Reference Section of the SEC, 450 Fifth Street, N.W., Room 1024, Washington,
D.C. 20549, at prescribed rates. You may obtain information on the operation of
the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also
maintains an Internet world wide web site that contains reports, proxy
statements and other information about issuers, like us, that file
electronically with the SEC. The address of that site is http://www.sec.gov.
You may also inspect reports, proxy statements and other information about us
at the offices of the Nasdaq Stock Market, 9600 Blackwell Road, Rockville,
Maryland 20850.
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to "incorporate by reference" information into this
prospectus from documents that we have previously filed with the SEC. This
means that we can disclose important information to you by referring you to
another document filed separately with the SEC. These documents contain
important information about us and our financial condition. The information
incorporated by reference is considered to be a part of this prospectus, except
for any information that is superseded by other information that is set forth
directly in this document.
This prospectus incorporates by reference the following documents with
respect to us (file number: 0-20488):
1.
Our annual report on Form 10-K for the year ended December
31, 2003;
2.
Our quarterly reports on Form 10-Q for the quarters ended
March 31, 2004 and June 30, 2004;
3.
Our current reports on Form 8-K dated March 3, 2004, as
amended on May 12, 2004, and June 2, 2004, as amended on August 10,
2004;
4.
The description of our common stock contained in registration
statement on Form S-4 filed with the SEC on June 12, 2002, as
amended July 11, 2002.
We incorporate by reference additional documents that we will file with
the SEC pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act
between the date of this prospectus and the termination dates of the Incentive
Plan and the Outside Directors' Plan. These documents include periodic
reports, such as annual reports on Form 10-K, quarterly reports on Form 10-Q
and current reports on Form 8-K, as well as proxy statements.
To the extent that any statement in this prospectus is inconsistent with
any statement that is incorporated by reference, the statement in this
prospectus shall control. The incorporated statement shall not be deemed,
except as modified or superseded, to constitute a part of this prospectus or
the registration statement.
You may obtain copies of the documents incorporated by reference in this
prospectus with respect to us without charge, excluding any exhibits to those
documents unless the exhibit is specifically incorporated by reference as an
exhibit in this prospectus, by requesting them in writing or by telephone from
Brent Turner, Investor Relations, Psychiatric Solutions, Inc., 840 Crescent
Centre Drive, Suite 460, Franklin, Tennessee 37067; (615) 312-5700. You may
also obtain copies of these documents from the SEC through the SEC's Internet
world wide web site or at the SEC's address or phone number described in the
section captioned "AVAILABLE INFORMATION" above.
We have filed with the SEC a registration statement on Form S-8 under the
Securities Act with respect to Common Stock offered under this prospectus.
This prospectus does not contain all of
2
Table of Contents
the information in the registration
statement on Form S-8, parts of which we have omitted, as allowed under the
rules and regulations of the SEC. You should refer to the registration
statement on Form S-8 for further information with respect to us and our Common
Stock. Statements contained in this prospectus as to the contents of any
contract or other document are not necessarily complete and, in each instance,
we refer you to the copy of each contract or document filed as an exhibit to
the registration statement on Form S-8. Copies of the registration statement
on Form S-8, including exhibits, may be inspected without charge at the SEC's
principal office in Washington, D.C. and copied upon payment of the fees
prescribed by the SEC.
LEGAL MATTERS
The validity of shares of our Common Stock offered under this prospectus
will be passed upon on our behalf by Waller Lansden Dortch & Davis, PLLC,
Nashville, Tennessee.
EXPERTS
The
consolidated financial statements of Psychiatric Solutions appearing
in Psychiatric Solutions' Annual Report (Form 10-K) for the year
ended December 31, 2003, have been audited by Ernst & Young
LLP, independent registered public accounting firm, as set forth in
their report thereon included therein and incorporated herein by
reference. Such consolidated financial statements are incorporated
herein by reference in reliance upon such report given on the
authority of such firm as experts in accounting and auditing.
The consolidated financial statements of Brentwood Health Management, LLC
and subsidiaries as of December 31, 2003 and for the year then ended
incorporated in this registration statement by reference from the Amended
Current Report on Form 8-K/A filed by Psychiatric Solutions, Inc. on May 12,
2004, have been audited by Crowe Chizek and Company LLC, independent registered
public accounting firm, as stated in their report, which is incorporated herein
by reference, and has been so incorporated in reliance upon the report of such
firm given upon their authority as experts in auditing and accounting.
The combined financial statements of Northern Healthcare Associates and
subsidiaries for the years ended December 31, 2003 and 2002 incorporated in
this registration statement by reference from the Amended Current Report on
Form 8-K/A filed by Psychiatric Solutions, Inc. on August 10, 2004, have been
audited by Selznick & Company, LLP, independent registered public accounting
firm, as stated in their report, which is incorporated herein by reference, and
has been so incorporated in reliance upon the report of such firm given their
authority as experts in auditing and accounting.
NO DEALER, SALESMAN OR ANY OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY
INFORMATION OR TO MAKE ANY REPRESENTATIONS OTHER THAN THOSE CONTAINED IN THIS
PROSPECTUS IN CONNECTION WITH THE OFFERING HEREIN CONTAINED AND, IF GIVEN OR
MADE, SUCH INFORMATION OR REPRESENTATIONS MUST NOT BE RELIED UPON AS HAVING
BEEN AUTHORIZED BY PSYCHIATRIC SOLUTIONS OR THE SELLING STOCKHOLDERS. THIS
PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL, OR A SOLICITATION OF ANY OFFER
TO BUY, THE SECURITIES OFFERED HEREBY IN ANY JURISDICTION OR TO ANY PERSON WHOM
IT IS UNLAWFUL TO MAKE AN OFFER OR SOLICITATION. NEITHER THE DELIVERY OF THIS
PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES, CREATE
AN IMPLICATION THAT THERE HAS
BEEN NO CHANGE IN THE AFFAIRS OF THE COMPANY SINCE THE DATE HEREOF OR
3
Table of Contents
THAT
ANY INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO ITS
DATE.
4
Table of Contents
EXPLANATORY NOTE
This registration statement on Form S-8 relates to the registration of an
additional 1,789,723 shares of Common Stock (the "Additional Shares"). The
Additional Shares are securities of the same class as those shares registered
in the Registrant's registration statements on Form S-8, previously filed with
the SEC (Registration Nos. 333-38419, 333-94983, 333-100635 and 33-72664) filed
on October 21, 1997, January 19, 2000, October 18, 2002 and December 8, 1993,
respectively, which, pursuant to General Instruction E of Form S-8, are
incorporated by reference herein.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 6. Indemnification of Directors and Officers.
Under Section 145 of the Delaware Corporation Law, we are empowered to
indemnify our directors and officers in circumstances therein provided.
Our Amended and Restated Certificate of Incorporation, as amended,
provides that no director shall be personally liable to us or our stockholders
for monetary damages for any breach of fiduciary duty by such director as a
director, except (i) for breach of the director's duty of loyalty to us or our
stockholders, (ii) for acts or omissions not in good faith or which involve
intentional misconduct or a knowing violation of law, (iii) pursuant to Section
174 of the Delaware General Corporation Law, or (iv) for any transaction from
which the director derived an improper personal benefit.
Under our Amended and Restated Bylaws, we must indemnify any person who
was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative (other than an action by or in the right of
Psychiatric Solutions) by reason of the fact that he or she is or was a
director, officer, employee or agent of Psychiatric Solutions, or is or was
serving at our request as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against
expenses (including attorneys' fees), judgments, fines and amounts paid in
settlement actually and reasonably incurred by him or her in connection with
such action, suit or proceeding if he or she acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to our best
interests, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his or her conduct was unlawful. The termination of
any action, suit or proceeding by judgment, order, settlement, conviction, or
upon a plea of nolo contendere or its equivalent, shall not, of itself, create
a presumption that the person did not act in good faith and in a manner which
he or she reasonably believed to be in or not opposed to our best interests,
and, with respect to any criminal action or proceeding, had reasonable cause to
believe that his or her conduct was unlawful.
We must also indemnify any person who was or is a party or is threatened
to be made a party to any threatened, pending or completed action or suit by or
in the right of Psychiatric Solutions to procure a judgment in its favor by
reason of the fact that he or she is or was a director, officer, employee or
agent of Psychiatric Solutions, or is or was serving at our request as a
director, officer, employee or agent of another corporation, partnership, joint
venture, trust or other enterprise against expenses (including attorneys' fees)
actually and reasonably incurred by him or her in connection with the defense
or settlement of such action or suit if he or she acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to our best
interests, except that no indemnification shall be made in respect of any
claim, issue or matter as to which such person shall have been adjudged to be
liable for negligence or misconduct in the performance of his duty to us
Table of Contents
unless and only to the extent that the Court of Chancery or the court in
which such action or suit was brought shall determine upon application that,
despite the adjudication of liability but in view of all the circumstances of
the case, such person is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery or such other court shall deem proper.
We may purchase and maintain insurance, at our expense, to protect us and
any of our directors, officers, employees or agents or the directors, officers,
employees or agents of another corporation, partnership, joint venture, trust
or other enterprise, against any such expense, liability or loss, to the
fullest extent permitted by the Delaware General Corporation Law.
Pursuant to separate indemnification agreements we have entered into with
each of our directors, we must indemnify and advance expenses to each director
to the fullest extent permitted by law and as set forth in each agreement and,
to the extent applicable, maintain insurance for the coverage of each director
under our policies of directors' and officers' liability insurance.
Item 8. Exhibits.
Exhibit
Number
Description of Exhibits
3.1
Amended and Restated Certificate of Incorporation of PMR Corporation,
filed with the Delaware Secretary of State on March 9, 1998 (incorporated
by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K
for the fiscal year ended April 30, 1998).
3.2
Certificate of Amendment to Amended and Restated Certificate of
Incorporation of PMR Corporation, filed with the Delaware Secretary of
State on August 5, 2002 (incorporated by reference to Exhibit 3.2 to the
Company's Quarterly Report on Form 10-Q for the quarter ended July 31,
2002).
3.3
Certificate of Amendment to Amended and Restated Certificate of
Incorporation of Psychiatric Solutions, Inc., filed with the Delaware
Secretary of State on March 21, 2003 (incorporated by reference to
Appendix A of the Company's Definitive Proxy Statement, filed on January
22, 2003).
3.4
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to
the Company's Annual Report on Form 10-K for the fiscal year ended April
30, 1997).
4.1
Reference is made to Exhibits 3.1 through 3.4.
4.2
Common Stock Specimen Certificate (incorporated by reference to Exhibit
4.2 to the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 2002).
4.3
Contingent Value Rights Agreement, dated August 2, 2002 (incorporated by
reference to Exhibit 4.1 to the Company's Current Report on Form 8-K,
filed on August 5, 2002).
4.4
Stock Purchase Agreement, dated as of January 6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix B of the Company's Definitive Proxy Statement,
filed January 22, 2003).
Table of Contents
Exhibit
Number
Description of Exhibits
4.5
Registration Rights Agreement, dated as of January 6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix C of the Company's Definitive Proxy Statement,
filed January 22, 2003).
4.6
Certificate of Designations, Preferences and Rights of Series A
Convertible Preferred Stock, filed with the Delaware Secretary of State on
March 24, 2003 (incorporated by reference to Appendix D of the Company's
Definitive Proxy Statement, filed January 22, 2003).
5.1*
Opinion of Waller Lansden Dortch & Davis, PLLC
23.1*
Consent of Ernst & Young LLP
23.2*
Consent of Crowe Chizek and Company LLC
23.3*
Consent of Selznick & Company, LLP
23.4*
Consent of Waller Lansden Dortch & Davis, PLLC (included in Exhibit 5.1)
24.1*
Power of Attorney (included on page II-6)
99.1
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(incorporated by reference to Appendix A to the Company's Definitive Proxy
Statement, filed on April 9, 2004)
99.2
Amended and Restated Psychiatric Solutions, Inc. Outside Directors' Stock
Option Plan (incorporated by reference to Appendix C to the Company's
Definitive Proxy Statement, filed on April 14, 2003)
*Filed herewith
Table of Contents
Item 9. Undertakings.
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of
the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information
set forth in the registration statement. Notwithstanding the
foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price
represent no more than a 20 percent change in the maximum aggregate
offering price set forth in the "Calculation of Registration Fee"
table in the effective registration statement;
(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration
statement or any material change of such information in the
registration statement.
Provided, however
, that paragraphs 1(i) and 1(ii) do not apply if
the information required to be included in a post-effective amendment by
those paragraphs is contained in periodic reports filed with or furnished
to the Commission by the registrant pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934 that are incorporated by reference in
the registration statement.
(2) That, for the purposes of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at
the termination of the offering.
(b) The undersigned registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d) of the
Securities Exchange Act of 1934) that is incorporated by reference in the
registration statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the
Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been informed that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is therefore unenforceable. In the event that a claim for
indemnification against such liabilities (other
Table of Contents
than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of
any action, suit or proceeding) is asserted by such director, officer or
controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Act and will be governed by the final adjudication of such
issue.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Franklin, State of Tennessee, on August 9, 2004.
PSYCHIATRIC SOLUTIONS, INC.
By:
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief Executive Officer
and President
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below constitutes and appoints Joey A. Jacobs and Jack E. Polson, and each of
them, his true and lawful attorney-in-fact, as agent and with full power of
substitution and resubstitution for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments to this Registration
Statement, and to file the same, with all exhibits thereto and other documents
in connection therewith, with the Securities and Exchange Commission, granting
unto said attorney-in-fact and agents full power and authority to do and
perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully and to all intents and purposes as they might or
could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents or any substitute or substitutes of any of them,
may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
SIGNATURE
TITLE
DATE
/s/ Joey A. Jacobs
Joey A. Jacobs
Chairman, Chief
Executive Officer and
President (Principal
Executive Officer)
August 9, 2004
/s/ Jack E. Polson
Jack E. Polson
Chief Accounting Officer
(Principal Financial and
Accounting Officer)
August 9, 2004
/s/ William F. Carpenter III
Director
August 9, 2004
William F. Carpenter III
/s/ Mark P. Clein
Director
August 9, 2004
Mark P. Clein
/s/ Richard Gore
Director
August 9, 2004
Richard Gore
Table of Contents
SIGNATURE
TITLE
DATE
/s/ Christopher Grant, Jr.
Director
August 9, 2004
Christopher Grant, Jr.
/s/ Ann H. Lamont
Director
August 9, 2004
Ann H. Lamont
/s/ Edward K. Wissing
Director
August 9, 2004
Edward K. Wissing
Table of Contents
INDEX TO EXHIBITS
Exhibit
Number
Description of Exhibits
3.1
Amended and Restated Certificate of Incorporation of PMR Corporation,
filed with the Delaware Secretary of State on March 9, 1998 (incorporated
by reference to Exhibit 3.1 to the Company's Annual Report on Form 10-K
for the fiscal year ended April 30, 1998).
3.2
Certificate of Amendment to Amended and Restated Certificate of
Incorporation of PMR Corporation, filed with the Delaware Secretary of
State on August 5, 2002 (incorporated by reference to Exhibit 3.2 to the
Company's Quarterly Report on Form 10-Q for the quarter ended July 31,
2002).
3.3
Certificate of Amendment to Amended and Restated Certificate of
Incorporation of Psychiatric Solutions, Inc., filed with the Delaware
Secretary of State on March 21, 2003 (incorporated by reference to
Appendix A of the Company's Definitive Proxy Statement, filed on January
22, 2003).
3.4
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to
the Company's Annual Report on Form 10-K for the fiscal year ended April
30, 1997).
4.1
Reference is made to Exhibits 3.1 through 3.4.
4.2
Common Stock Specimen Certificate (incorporated by reference to Exhibit
4.2 to the Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 2002).
4.3
Contingent Value Rights Agreement, dated August 2, 2002 (incorporated by
reference to Exhibit 4.1 to the Company's Current Report on Form 8-K,
filed on August 5, 2002).
4.4
Stock Purchase Agreement, dated as of January 6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix B of the Company's Definitive Proxy Statement,
filed January 22, 2003).
4.5
Registration Rights Agreement, dated as of January 6, 2003, by and among
Psychiatric Solutions, Inc. and the Purchasers named therein (incorporated
by reference to Appendix C of the Company's Definitive Proxy Statement,
filed January 22, 2003).
4.6
Certificate of Designations, Preferences and Rights of Series A
Convertible Preferred Stock, filed with the Delaware Secretary of State on
March 24, 2003 (incorporated by reference to Appendix D of the Company's
Definitive Proxy Statement, filed January 22, 2003).
5.1*
Opinion of Waller Lansden Dortch & Davis, PLLC
23.1*
Consent of Ernst & Young LLP
23.2*
Consent of Crowe Chizek and Company LLC
Table of Contents
Exhibit
Number
Description of Exhibits
23.3*
Consent of Selznick & Company, LLP
23.4*
Consent of Waller Lansden Dortch & Davis, PLLC (included in Exhibit 5.1)
24.1*
Power of Attorney (included on page II-6)
99.1
Amended and Restated Psychiatric Solutions, Inc. Equity Incentive Plan
(incorporated by reference to Appendix A to the Company's Definitive Proxy
Statement, filed on April 9, 2004)
99.2
Amended and Restated Psychiatric Solutions, Inc. Outside Directors' Stock
Option Plan (incorporated by reference to Appendix C to the Company's
Definitive Proxy Statement, filed April 14, 2003)
*Filed herewith